9.07
price down icon4.53%   -0.43
after-market Dopo l'orario di chiusura: 9.25 0.18 +1.98%
loading
Precedente Chiudi:
$9.50
Aprire:
$9.45
Volume 24 ore:
176.80K
Relative Volume:
0.52
Capitalizzazione di mercato:
$297.48M
Reddito:
$65.42M
Utile/perdita netta:
$-32.96M
Rapporto P/E:
-7.1417
EPS:
-1.27
Flusso di cassa netto:
$-19.87M
1 W Prestazione:
-0.11%
1M Prestazione:
-15.71%
6M Prestazione:
-38.24%
1 anno Prestazione:
+12.39%
Intervallo 1D:
Value
$9.06
$9.45
Intervallo di 1 settimana:
Value
$9.00
$9.61
Portata 52W:
Value
$5.45
$18.98

Neuropace Inc Stock (NPCE) Company Profile

Name
Nome
Neuropace Inc
Name
Telefono
(650) 237-2700
Name
Indirizzo
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
Name
Dipendente
195
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-04
Name
Ultimi documenti SEC
Name
NPCE's Discussions on Twitter

Confronta NPCE con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
NPCE
Neuropace Inc
9.07 306.67M 65.42M -32.96M -19.87M -1.27
Medical Devices icon
ABT
Abbott Laboratories
125.64 218.92B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.21 152.62B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
396.66 153.22B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
92.32 117.89B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
75.80 45.12B 5.54B 4.18B 623.10M 7.00

Neuropace Inc Stock (NPCE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-28 Iniziato H.C. Wainwright Buy
2025-01-21 Iniziato UBS Buy
2024-03-14 Aggiornamento Wells Fargo Equal Weight → Overweight
2024-01-30 Iniziato Leerink Partners Outperform
2023-11-10 Iniziato Cantor Fitzgerald Overweight
2023-08-24 Aggiornamento Morgan Stanley Underweight → Equal-Weight
2023-02-22 Iniziato Lake Street Buy
2022-04-06 Iniziato Wolfe Research Outperform
2022-01-19 Downgrade Wells Fargo Overweight → Equal Weight
2022-01-07 Downgrade Morgan Stanley Equal-Weight → Underweight
2021-11-11 Downgrade Morgan Stanley Overweight → Equal-Weight
2021-08-18 Iniziato Robert W. Baird Outperform
2021-05-17 Iniziato JP Morgan Overweight
2021-05-17 Iniziato Morgan Stanley Overweight
2021-05-17 Iniziato SVB Leerink Outperform
2021-05-17 Iniziato Wells Fargo Overweight
Mostra tutto

Neuropace Inc Borsa (NPCE) Ultime notizie

pulisher
Jul 23, 2025

What analysts say about NeuroPace Inc. stockFastest return on investment - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

NeuroPace Inc. Stock Analysis and ForecastFree Bull & Bear Market Updates - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Is NeuroPace Inc. a good long term investmentPhenomenal capital gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives NeuroPace Inc. stock priceTriple-digit returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

NeuroPace, Inc. (NPCE) Backed by Cantor Fitzgerald Following Physician Survey - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

NeuroPace secures $75M credit facility with MidCap Financial - MSN

Jul 18, 2025
pulisher
Jul 17, 2025

(NPCE) Proactive Strategies - news.stocktradersdaily.com

Jul 17, 2025
pulisher
Jul 16, 2025

What makes NeuroPace Inc. stock price move sharplyFree Investing Community - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How NeuroPace Inc. stock performs during market volatilityFree Stock Selection - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why NeuroPace Inc. stock attracts strong analyst attentionFree Stock Market Query - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

NeuroPace appoints Patrick Williams as CFO - MSN

Jul 09, 2025
pulisher
Jul 07, 2025

NeuroPace’s SWOT analysis: innovative epilepsy treatment stock faces growth hurdles By Investing.com - Investing.com South Africa

Jul 07, 2025
pulisher
Jul 06, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, ... - Bluefield Daily Telegraph

Jul 06, 2025
pulisher
Jul 06, 2025

NeuroPace’s SWOT analysis: innovative epilepsy treatment stock faces growth hurdles - Investing.com

Jul 06, 2025
pulisher
Jun 29, 2025

NeuroPaceVolatile, Uncertain, But Promising (NASDAQ:NPCE) - Seeking Alpha

Jun 29, 2025
pulisher
Jun 27, 2025

NeuroPace Inc (NPCE) Trading Down 3.93% on Jun 27 - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc.NPCE - WV News

Jun 27, 2025
pulisher
Jun 26, 2025

NeuroPace stock maintains outperform rating at Leerink on expansion outlook - Investing.com

Jun 26, 2025
pulisher
Jun 25, 2025

NeuroPace stock rating reiterated at Overweight by Cantor Fitzgerald - Investing.com UK

Jun 25, 2025
pulisher
Jun 24, 2025

NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm - WV News

Jun 24, 2025
pulisher
Jun 24, 2025

NeuroPace's NAUTILUS Fallout: A Shareholder's Guide to Fraud Claims and Recovery - AInvest

Jun 24, 2025
pulisher
Jun 19, 2025

Is NeuroPace (NASDAQ:NPCE) Weighed On By Its Debt Load? - simplywall.st

Jun 19, 2025
pulisher
Jun 16, 2025

Metric Analysis: NeuroPace Inc (NPCE)’s Key Ratios in the Limelight - DWinneX

Jun 16, 2025
pulisher
Jun 16, 2025

10 Best NASDAQ Stocks Under $50 to Buy - Insider Monkey

Jun 16, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Invests $293,000 in NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Cantor Fitzgerald Comments on NeuroPace FY2026 Earnings - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Bank of America Corp DE Raises Position in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating NeuroPace, Inc. (NPCE) And Encourages Shareholders to Connect - ACCESS Newswire

Jun 13, 2025

Neuropace Inc Azioni (NPCE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$286.58
price down icon 0.03%
medical_devices STE
$227.25
price up icon 0.79%
medical_devices PHG
$25.84
price down icon 0.04%
$86.74
price up icon 0.36%
$76.77
price down icon 0.62%
medical_devices EW
$75.80
price down icon 1.44%
Capitalizzazione:     |  Volume (24 ore):